Imagion Biosystems Ltd (IBX) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.460x

Based on the latest financial reports, Imagion Biosystems Ltd (IBX) has a cash flow conversion efficiency ratio of 0.460x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.78 Million ≈ $-1.26 Million USD) by net assets (AU$-3.87 Million ≈ $-2.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Imagion Biosystems Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Imagion Biosystems Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read IBX total liabilities for a breakdown of total debt and financial obligations.

Imagion Biosystems Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Imagion Biosystems Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
CU Medical Systems Inc KQ:115480	0.055x
THG Holdings PLC LSE:THG	-0.134x
Viji Finance Limited NSE:VIJIFIN	0.017x
HIGH QUALITY FOOD F:L24	N/A
Eko Export SA WAR:EEX	-0.017x
Macarthur Minerals Ltd AU:MIO	-0.005x
Enlitic Inc AU:ENL	-0.698x
KWANGJIN WINTEC CO. Ltd KQ:090150	0.040x

Annual Cash Flow Conversion Efficiency for Imagion Biosystems Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of Imagion Biosystems Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see IBX company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$-2.28 Million ≈ $-1.62 Million	AU$-1.27 Million ≈ $-899.04K	0.557x	-74.65%
2023-12-31	AU$-3.79 Million ≈ $-2.68 Million	AU$-8.32 Million ≈ $-5.88 Million	2.195x	+227.18%
2022-12-31	AU$4.68 Million ≈ $3.31 Million	AU$-8.07 Million ≈ $-5.71 Million	-1.726x	-353.14%
2021-12-31	AU$13.31 Million ≈ $9.41 Million	AU$-5.07 Million ≈ $-3.59 Million	-0.381x	-6.41%
2020-12-31	AU$12.91 Million ≈ $9.14 Million	AU$-4.62 Million ≈ $-3.27 Million	-0.358x	+74.55%
2019-12-31	AU$2.97 Million ≈ $2.10 Million	AU$-4.18 Million ≈ $-2.96 Million	-1.406x	+33.10%
2018-12-31	AU$3.87 Million ≈ $2.74 Million	AU$-8.13 Million ≈ $-5.76 Million	-2.102x	-109.47%
2017-12-31	AU$6.95 Million ≈ $4.92 Million	AU$-6.98 Million ≈ $-4.94 Million	-1.004x	-4289.57%
2016-12-31	AU$11.69 Million ≈ $8.27 Million	AU$-267.26K ≈ $-189.10K	-0.023x	-104.80%
2015-12-31	AU$-8.86 Million ≈ $-6.27 Million	AU$-4.22 Million ≈ $-2.99 Million	0.477x	-22.14%
2014-12-31	AU$-3.97 Million ≈ $-2.81 Million	AU$-2.43 Million ≈ $-1.72 Million	0.612x	--

About Imagion Biosystems Ltd

AU:IBX Australia Diagnostics & Research

Market Cap

$5.90 Million

AU$8.34 Million AUD

Market Cap Rank

#28035 Global

#1515 in Australia

Share Price

AU$0.02

Change (1 day)

+21.43%

52-Week Range

AU$0.01 - AU$0.05

All Time High

AU$8.60